[Webinar] Burden of disease assessment for COVID-19: initial insights and future perspectives
As COVID-19 pandemic continue to unroll, more and more countries are assessing the population health impact of COVID-19. The burden of disease approach offers a framework that allows for comprehensive and comparable population health impact assessments, making it possible to compare the impact of COVID-19 to that of other diseases and risk factors.
In this webinar, we will unveil some initial estimates of the burden of COVID-19 at population level. We will also zoom in on post COVID conditions, which constitute a significant, but to date highly uncertain, contribution to the overall COVID-19 disease burden.
This webinar is jointly organized by the unCoVer network and the European Burden of Disease Network.
Programme - Friday 21 May 2021, 14h-15h CET
| 14h00 | Welcome & Introduction Prof Dr José Peñalvo, Institute of Tropical Medicine, Belgium |
| 14h05 | Disease burden of COVID-19 in Germany (with Q&A) Dr Elena von der Lippe, Robert Koch Institute, Germany |
| 14h20 | Disease burden of COVID-19 in Scotland (with Q&A) Mr Grant Wyper, Public Health Scotland, UK |
| 14h35 | Post COVID conditions: evolving immunological evidence and future perspectives (with Q&A) Dr Joe Breen, National Institute of Allergy and Infectious Diseases, USA |
| 14h50 | General discussion |
Registration
Click here to register for the webinar
Upon registration, you will receive a meeting invitation with the login details for the webinar.
Follow us!
PHIRI Work tools
 |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101018317. Disclaimer - Privacy policy |